Masako Ishikawa

Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma

Atsuko Katagiri, Kentaro Nakayama, Mohammed Tanjimur Rahman et al. · Modern Pathology · 2011 · 223 citations · Full text

Medicine, Cancer Biology, Oncology +16

Gene amplification <i>CCNE1</i> is related to poor survival and potential therapeutic target in ovarian cancer

Naomi Nakayama, Kentaro Nakayama, Shamima Yeasmin et al. · Cancer · 2010 · 205 citations

Medicine, Molecular Biology, Oncology +16

Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer

Hitomi Yamashita, Kentaro Nakayama, Masako Ishikawa et al. · Oncotarget · 2017 · 135 citations · Full text

Medicine, Gynecology, Oncology +15

CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas

Kentaro Nakayama, Mohammed Tanjimur Rahman, Munmun Rahman et al. · International Journal of Oncology · 2015 · 73 citations · Full text

Medicine, Molecular Biology, Oncology +12

Prognostic and therapeutic impact of the chromosome 20q13.2 <i>ZNF217</i> locus amplification in ovarian clear cell carcinoma

Mohammed Tanjimur Rahman, Kentaro Nakayama, Munmun Rahman et al. · Cancer · 2011 · 66 citations · Full text

Medicine, Molecular Biology, Oncology +17